Agilent Technologies (NYSE:A – Get Free Report) updated its first quarter earnings guidance on Monday. The company provided EPS guidance of $1.20-1.23 for the period, compared to the consensus EPS estimate of $1.34. The company issued revenue guidance of $1.555-1.605 billion, compared to the consensus revenue estimate of $1.67 billion. Agilent Technologies also updated its FY 2024 guidance to $5.44-$5.55 EPS.
Analyst Ratings Changes
Several equities analysts recently commented on the stock. Jefferies Financial Group cut their target price on shares of Agilent Technologies from $150.00 to $146.00 and set a buy rating for the company in a research note on Wednesday, August 16th. UBS Group cut shares of Agilent Technologies from a buy rating to a neutral rating and dropped their price objective for the company from $163.00 to $125.00 in a research note on Friday. Barclays dropped their price objective on shares of Agilent Technologies from $110.00 to $105.00 and set an underweight rating for the company in a research note on Friday, September 29th. Sanford C. Bernstein initiated coverage on shares of Agilent Technologies in a research note on Thursday, September 28th. They issued a market perform rating and a $123.00 price objective for the company. Finally, TheStreet cut shares of Agilent Technologies from a b rating to a c+ rating in a research note on Tuesday, August 15th. One analyst has rated the stock with a sell rating, five have given a hold rating and eleven have issued a buy rating to the stock. Based on data from MarketBeat.com, the company presently has an average rating of Moderate Buy and an average target price of $143.94.
Agilent Technologies Stock Up 0.7 %
Agilent Technologies (NYSE:A – Get Free Report) last issued its quarterly earnings data on Monday, November 20th. The medical research company reported $1.38 EPS for the quarter, topping analysts’ consensus estimates of $1.34 by $0.04. The firm had revenue of $1.69 billion for the quarter, compared to analyst estimates of $1.67 billion. Agilent Technologies had a net margin of 16.20% and a return on equity of 29.86%. The company’s revenue was down 8.7% on a year-over-year basis. During the same quarter in the prior year, the firm earned $1.53 EPS. As a group, research analysts forecast that Agilent Technologies will post 5.41 EPS for the current fiscal year.
Agilent Technologies Increases Dividend
The firm also recently announced a quarterly dividend, which will be paid on Wednesday, January 24th. Stockholders of record on Tuesday, January 2nd will be paid a $0.236 dividend. This represents a $0.94 annualized dividend and a dividend yield of 0.83%. The ex-dividend date is Friday, December 29th. This is a positive change from Agilent Technologies’s previous quarterly dividend of $0.23. Agilent Technologies’s dividend payout ratio (DPR) is 24.61%.
In other news, VP Rodney Gonsalves sold 3,500 shares of the firm’s stock in a transaction dated Wednesday, August 23rd. The shares were sold at an average price of $118.78, for a total value of $415,730.00. Following the transaction, the vice president now owns 24,219 shares of the company’s stock, valued at approximately $2,876,732.82. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Insiders own 0.31% of the company’s stock.
Institutional Trading of Agilent Technologies
A number of hedge funds have recently modified their holdings of the company. Vanguard Group Inc. raised its position in shares of Agilent Technologies by 1.1% in the 1st quarter. Vanguard Group Inc. now owns 24,531,170 shares of the medical research company’s stock valued at $3,246,209,000 after acquiring an additional 261,435 shares during the period. Geode Capital Management LLC raised its position in shares of Agilent Technologies by 2.0% in the 1st quarter. Geode Capital Management LLC now owns 6,203,779 shares of the medical research company’s stock valued at $856,310,000 after acquiring an additional 122,329 shares during the period. Morgan Stanley raised its position in shares of Agilent Technologies by 79.4% in the 4th quarter. Morgan Stanley now owns 4,145,767 shares of the medical research company’s stock valued at $620,414,000 after acquiring an additional 1,835,413 shares during the period. JPMorgan Chase & Co. raised its position in shares of Agilent Technologies by 16.2% in the 1st quarter. JPMorgan Chase & Co. now owns 2,769,368 shares of the medical research company’s stock valued at $383,114,000 after acquiring an additional 386,125 shares during the period. Finally, Norges Bank acquired a new stake in shares of Agilent Technologies in the 4th quarter valued at approximately $393,291,000. 85.42% of the stock is currently owned by institutional investors and hedge funds.
Agilent Technologies Company Profile
Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; vacuum pumps, and measurement technologies.
- Five stocks we like better than Agilent Technologies
- How to Buy Gold Stock and Invest in Gold
- Safeguard your portfolio with these three bargain stocks
- How is Compound Interest Calculated?
- Membership clubs gain leverage for the consumer rebound
- How to Invest in Canada for Beginners
- Advanced Auto Parts may be worth more in pieces than the whole
Receive News & Ratings for Agilent Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies and related companies with MarketBeat.com's FREE daily email newsletter.